Which class of medication is Donepezil?

Donepezil belongs to the class of medications known as acetylcholinesterase inhibitors. This class of drugs works by inhibiting the enzyme acetylcholinesterase, which breaks down acetylcholine, a neurotransmitter that is important for memory and learning. By preventing the breakdown of acetylcholine, Donepezil increases the levels of this neurotransmitter in the brain, which can help improve cognitive function in individuals with Alzheimer's disease.

Acetylcholinesterase inhibitors are commonly used in the treatment of mild to moderate Alzheimer's disease to enhance cognitive function and potentially slow the progression of symptoms. Their mechanism of action is particularly relevant for Alzheimer’s patients, as they experience a decline in cholinergic activity related to cognitive decline.

The other classes of medications mentioned, such as beta-blockers, antidepressants, and antipsychotics, serve different purposes in the treatment of various medical conditions and do not impact the cholinergic system in the same way that acetylcholinesterase inhibitors do. Thus, Donepezil's specific role in managing cognitive symptoms of Alzheimer's disease makes it distinctly classified as an acetylcholinesterase inhibitor.